Early Detection

The Early Detection Research Group (EDRG) supports research that seeks to determine the effectiveness, operating characteristics, and clinical impact (harms as well as benefits) of cancer early detection technologies and practices, such as imaging and molecular biomarker approaches.

Read more About the Early Detection Research Group.

Staff

Funding Opportunities

Grants

Publications

Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

A large randomized trial designed to determine the effects of screening on cancer-related mortality and secondary endpoints in people aged 55 to 74. Researchers can request valuable PLCO data and biospecimens.

Cancer Data Access System (CDAS)

Submission and tracking for data from the National Lung Screening Trial and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

The National Lung Screening Trial (NLST)

A lung cancer screening trial that compared two ways of detecting lung cancer: low-dose helical (spiral) computed tomography (CT) and standard chest x-ray. Researchers can request NLST data sets, CT images, and pathology images.

News and Events

NIH Launches Research Network to Evaluate Emerging Cancer Screening Technologies
Date Posted: February 21, 2024

Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023

Alliance of Pancreatic Cancer Consortia (APaCC), and the European Liquid Biopsy Society Workshop on Extracellular Vesicles in Early Detection of Pancreatic Cancer meeting
Date Posted: April 11, 2023

PCDC EDRN-APaCC Joint (Virtual) Meeting
Date Posted: November 9, 2021